KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line Chemotherapy
Clinical trial NCT01487174 · TERMINATED
Trial details
- NCT number
- NCT01487174
- Sponsor
- Kadmon Corporation, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-14
- Primary completion
- 2013-07-25
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.